Prevention of Suicidal Behavior Through the VIGILANS Protocol: the Restoration of Social Connection Hypothesis
Recruiting
N/A
Interventional Study
Suicidal Behaviour Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 120 (estimated)
- Sponsor
- University Hospital, Montpellier · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The World Health Organization (WHO) estimates, with 800,000 annual deaths, that suicide is the second leading cause of death in people aged 10 to 44 and thus recognizes suicide prevention as a public health priority. The psychological impact of the COVID-19 pandemic, the social isolation and the economic consequences engendered by the confinement, as well as the direct effects of this viral infect…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
For all subjects:
* Patients benefiting from VigilanS monitoring at CHU Montpellier / Nîmes
* aged between 18 and 55 years old;
* able to understand experimental procedures
* able to speak, read and understand French
* able to give written informed consent
Specific inclusion criteria:
TS+: Had an…
Contacts